transfer of free cholesterol ( 3 ). Moreover, PLTP has been implicated in hepatic apoB-containing particle secretion ( 4 ). Consistent with its role in lipoprotein metabolism, Pltp is regulated by liver X receptor (LXR) ( 5 ) and farnesoid X receptor (FXR) ( 6 ), which are regulators of bile metabolism. Pltp overexpression has been associated with increased cholesterol and phospholipids output via the bile ( 7 ).
Fast phase liquid chromatography
Lipoprotein profi les were obtained by fast-phase liquid chromatography (FPLC) using two Sepharose 6B columns in tandem. A 250 l aliquot of pooled plasma was loaded onto the columns and eluted with FPLC buffer (50 mM Tris) at a constant fl ow rate of 0.35 ml/min. An aliquot of 100 l from each fraction was used for the determination of lipids.
Quantitative analysis of atherosclerosis
Atherosclerosis was determined as previously described ( 19 ) . Briefl y, Pltp KO/ Apoe KO and Apoe KO mice were fed the high-fat diet for 7 weeks. The heart was fi xed in 4% formaldehyde and then embedded in paraffi n. The aortic root was sectioned into 7 µm thick slices and then stained with Harris's hematoxylin and eosin. Five sections from each aortic root, 30 µm apart from each other, were imaged and captured with a Nikon Labophot 2 microscope equipped with a SPOT RT3 color camera. The average area of these aortic root lesions from each animal was quantifi ed using Image J software.
Electron microscopy
Negative-stain electron microscopy was performed as described in Refs. 20 and 2 with modifi cations. NonHDL lipoprotein particles isolated by FPLC and fractions were concentrated using centrifugal fi lter devices (Millipore). Following concentration, the solvent was changed to 125 mM ammonium acetate, 2.6 mM ammonium carbonate, and 0.26 mM EDTA (pH 7.4), and this solution was mixed with an equal volume of 2% phosphotungstic acid (pH 7.4). Then 10 µl of lipoprotein solution was applied to a carbon/Formvar-coated copper grid (Electron Microscopy Sciences). Excess fl uid was removed with fi lter paper after 20 s, and the grid was viewed immediately.
Conjugated dienes formation
NonHDL lipoprotein particles were isolated by FPLC, and fractions were concentrated using centrifugal fi lter devices (Millipore). Lipoproteins were oxidized in the presence of 5 µM CuSO4, and the formation of conjugated dienes was monitored at 234 nm every 5 min over a 5 h period using an UV spectrophotometer (Beckman DU 530).
In vivo clearance of nonHDL free cholesterol
NonHDL lipoprotein was labeled with [ 3 H] free cholesterol in a two-step procedure. First, 2.5 ml of pooled plasma from Pltp KO mice was incubated with 100 × 10 6 cpm of [ 3 H] free cholesterol in the presence of the LCAT inhibitor DTNB (fi nal concentration 5 mM) for 16 h at room temperature. Total cholesterol and free cholesterol were assayed from plasma before and after labeling to check for cholesterol esterifi cation. Second, labeled nonHDL lipoproteins were separated from other plasma components by density centrifugation at 1.063 g/l. The supernatant, containing nonHDL lipoproteins, was dialyzed against PBS. Finally, 1 million cpm of [ 3 H] free cholesterol labeled nonHDL lipoprotein was injected into each of COD-fed Pltp KO and WT mice (n = 4 per group) via the retro-orbital plexus. Plasma was counted for radioactivity at 5, 15, 30 min and at 1, 2, 4, 8 and 24 h after injection. The label should be distributed evenly throughout the circulatory system at 5 min after injection. Therefore, cpm in plasma at 5 min was considered to be the starting cpm. All data was expressed as a percentage of the respective 5 min plasma cpm.
VLDL lipid secretion
Secretion of lipids from VLDL was measured as the accumulation of VLDL lipids in plasma after VLDL clearance was inhibited. Pltp KO and WT mice (n = 4 per group) were fed COD for cholesterol loading induces macrophage death ( 11 ) , which is considered to be atherogenic in a late lesion due to ineffective clearance of necrotic cells ( 12 ) . More over, free cholesterol loading of macrophages induces synthesis and secretion of proinfl ammatory and proatherogenic cytokines, such as TNF-␣ and IL-6 ( 13 ) . In general, the in vivo consequences of plasma free cholesterol accumulation on atherosclerosis have not been well studied due to the scarcity of mouse models with elevated plasma free cholesterol. So far, only one mouse model, the scavenger receptor B-I ( Srb1 ) KO mice, showed the proatherogenic consequence of free cholesterol accumulation in the blood ( 14 ) .
Elevated plasma phospholipids, especially on apoBcontaining lipoproteins, can be atherogenic as well. Phospholipids, particularly those containing poly-unsaturated fatty acids (PUFA), are susceptible to free-radical or enzymatic oxidation by enzymes such as myeloperoxidase and lypoxygenase in the arterial vessel wall. Oxidized phospholipids on LDL (oxLDL) activate endothelial cells, leading to recruitment of monocytes into the vessel intima ( 15 ) . Once inside the vessel wall, oxLDL can be taken up by macrophages, transforming them into proinfl ammatory and proatherogenic foam cells. Beyond oxidized phospholipids, sphingomyelin, the second most abundant plasma phospholipid, is also atherogenic. Sphingomyelin on apoB-containing lipoproteins can be hydrolyzed by sphingomyelinase in the vessel intima, leading to aggregation and retention of these particles in the vessel wall ( 16 ) .
In this study, we examined the atherogenic consequence in COD-fed Pltp/Apoe KO mice and explored possible mechanisms leading to COD-induced lipid accumulation. We found that COD-fed Pltp -defi cient mice are no longer protected from atherosclerosis and have impaired biliary lipid secretion.
METHODS

Animals and diets
All mice used in this study were in the C57BL/6J genetic background. At 13 weeks of age, female Pltp KO/ Apoe KO and Apoe KO mice were fed a high-fat diet enriched with coconut oil (see below) for 7 weeks and were assessed for atherosclerosis. At 14-16 weeks of age, female Pltp KO or wild-type (WT) mice were used in the mechanism study. These mice were fed the same high-fat diet for 2 weeks. All animal procedures were approved by the SUNY Downstate Medical Centre Animal Care and Use Committee.
Mice were fed chow diet (Purina Laboratory Rodent Chow 5001) or chow diet supplemented with 20% hydrogenated coconut oil (100% saturated fat) and 0.15% cholesterol (COD) (Research Diets Inc., New Brunswick, NJ).
Lipid measurements
Fasted blood was collected for lipoprotein isolation and lipid measurement. Plasma total cholesterol, free cholesterol, phospholipids, and lipoproteins were assayed by enzymatic methods (Wako). Sphingomyelin was measured by an established method ( 17 ) . HDL lipid concentrations were determined after nonHDL lipoproteins were precipitated from plasma using a 10× solution of 1% dextran sulfate (50,000 MW) and 500 mM MgCl 2 (pH 7.0), as described in ( 18 ) . cholesterol, free cholesterol, total phospholipids, and sphingomyelin but not triglyceride levels ( Table 1 ) . These results confi rmed what we had observed before ( 4 ) . We also noticed that the ratio of total cholesterol to free cholesterol was not signifi cantly different between Pltp KO/ Apoe KO and Apoe KO mice ( Table 1 ) .
We next examined the effect of COD on plasma lipid levels in Pltp KO/ Apoe KO and Apoe KO mice, as we observed that feeding COD signifi cantly increased plasma free cholesterol levels in all Pltp -defi cient mice ( 2, 8 ) . In response to COD, there was a signifi cant increase, instead of decrease, in plasma free cholesterol (149%), sphingomyelin (54%), and total phospholipids (15%) in Pltp KO/ Apoe KO mice compared with Apoe KO mice ( Table 1 ). More importantly, we noticed that the ratio of total cholesterol to free cholesterol was signifi cantly ( P < 0.01) reduced from 3.48 ± 0.56 to 1.73 ± 0.27 ( Table 1 ), indicating that a signifi cant amount of free cholesterol accumulated in the circulation.
Next, we determined the distribution of free cholesterol and sphingomyelin in lipoproteins from Pltp KO/ Apoe KO mice and Apoe KO mice. Using FPLC, we resolved plasma lipoproteins into 50 fractions for free cholesterol and sphingomyelin measurements. This analysis revealed that COD ( Fig. 1B ), but not chow diet feeding ( Fig. 1A ) , caused more free cholesterol to accumulate in nonHDL-sized lipoproteins in Pltp KO/ Apoe KO mice compared with Apoe KO mice. This was also true for sphingomyelin levels ( 
Negative-stain electron microscopy of plasma lipoprotein particles
COD feeding causes accumulation of plasma free cholesterol and phospholipids on 40-50 nm-sized, lamellarshaped particles in Pltp KO mice ( 26 ) . Here we characterized nonHDL-sized plasma lipoproteins from COD-fed Pltp KO/ Apoe and Apoe KO mice using electron microscopy. There were numerous lamellar-shaped particles in plasma from COD-fed Pltp KO/ Apoe KO mice, whereas these particles were very scarce in plasma from COD-fed Apoe KO mice ( Fig. 2 ) .
2 weeks and then fasted for 16 h. An inhibitor of lipoprotein lipase, P407, was utilized to inhibit VLDL clearance ( 21 ) . Plasma lipids were measured before and at 1 and 2 h after P407 injection (1 g/kg) ip. Lipid secretion rates are expressed as fold change of plasma lipid levels after P407 treatment.
Bile fl ow and lipid analysis
Pltp KO and WT mice (n = 4 per group) were utilized for biliary lipid secretion studies according to an established method ( 22 ) . Biliary cholesterol, phospholipids, and total and individual bile salts were determined as described previously ( 23 ) .
Plasma lipoprotein gel electrophoresis
Fresh plasma was either prestained with Sudan Black B or unstained and then spotted onto an agarose gel (Titan Lipoprotein Gel, Helena Laboratories) and subjected to electrophoresis according to the manufacturer's instructions. Plasma was prestained as previously described ( 24 ) . Briefl y, 2 µl of a saturated solution of Sudan Black B in 1 part petroleum ether and 4 parts ethyl alcohol were mixed with 20 µl of plasma. The mixture was centrifuged at 10,000 rpm for 5 min to remove any precipitated Sudan Black. Unstained plasma resolved on agarose gel was stained for free cholesterol using fi lipin as previously described ( 25 ) . The gel was fi rst fi xed for 1 h in TCA, then washed fi ve times with PBS. Subsequently, the gel was incubated with 0.01% fi lipin in PBS with 1% dimethylformamide for 16 h. Filipin was visualized using a UV transilluminator.
Plasma total bile acid measurement
Plasma total bile acids were measured by the enzyme cycling method (Diazyme) according to the manufacturer's instructions.
Statistical analysis
Data are expressed as mean ± SD. Differences between groups were tested by two-tailed t-test, assuming unequal variance. A P value of less than 0.05 was considered signifi cant.
RESULTS
Pltp KO/ Apoe KO mice have a proatherogenic plasma lipid profi le when fed a coconut oil-enriched, high-fat diet Plasma lipid analysis showed that on chow diet, Pltp defi ciency in Apoe KO background signifi cantly reduced total lesterol and sphingomyelin, which may promote atherogenesis. Moreover, nonHDL from COD-fed Pltp KO/ Apoe KO mice were more susceptible to oxidation and, therefore, more atherogenic. We measured atherosclerotic lesions in COD-fed Pltp KO/ Apoe and Apoe KO mice using two techniques: imaging the intact aortic arch ( Fig. 4A , B ) and examining tissue sections from the aortic root ( Fig. 4C, D ) . We did not fi nd signifi cant differences in lesion size between two groups of animals ( Fig. 4 ) . These results showed that Pltp defi ciency was no longer antiatherogenic in animals fed a coconut oil-enriched diet.
Potential mechanism(s) of free cholesterol accumulation in COD-fed Pltp KO mice
Feeding COD has been shown to cause nonHDL free cholesterol accumulation in multiple Pltp -defi cient mouse models ( 8, 27 ) , including Pltp KO/ Apoe KO mice. More-
Conjugated dienes formation
COD-fed Pltp KO/ Apoe KO mice have elevated nonHDL plasma phospholipids ( Table 1 ) , which if oxidized, can become atherogenic. Therefore, we assayed for levels of oxidizable lipoproteins in these mice relative to controls. We isolated nonHDL particles from Pltp KO/ Apoe and Apoe KO mice using FPLC and monitored conjugated diene formation during oxidation by copper sulfate ( Fig. 3 ) . On COD, nonHDL particles from Pltp KO/ Apoe KO mice were more susceptible to oxidation than nonHDL particles from Apoe KO mice ( Fig. 3 ) .
Atherosclerosis in COD-fed Pltp KO/ Apoe KO mice
It is known that on chow diet, Pltp KO/ Apoe KO mice have less plasma cholesterol and less atherosclerotic lesion compared with Apoe KO mice ( 4 ). However, COD-fed Pltp KO/ Apoe KO mice accumulated plasma nonHDL free cho- Table I ). In addition, we stained agarose gel-resolved plasma with fi lipin, a specifi c dye for free cholesterol, and found COD-fed non-HDL particles from Pltp KO mice stain more intensely compared with WT controls ( Fig. 5 ) . Therefore, we focused on the pathways relevant to the steady-state levels of nonHDL lipoprotein free cholesterol. First, we considered an increase in the clearance of nonHDL-particle free cholesterol in vivo as a potential mechanism for free cholesterol accumulation in the blood. We injected [ 3 H] cholesterol-nonHDL particles into Pltp KO and WT mice via the retro-orbital plexus, and [
3 H] levels remaining in plasma were monitored over a course of 24 h. Interesting, this analysis demonstrated that COD-fed Pltp KO mice had slightly faster nonHDL-particle free cholesterol clearance rate than that of WT controls ( Fig. 6 ) .
Having ruled out nonHDL free cholesterol clearance as the potential mechanism, we next asked if the in vivo secretion of nonHDL lipoprotein free cholesterol from the liver was affected. The synthetic surfactant P-407 inhibits VLDL clearance from plasma ( 21 ) and is therefore a valuable tool for studying lipids of VLDL particles secreted from the liver. Although free cholesterol can also be secreted from the liver through ATP-binding cassette (ABC) transporters to HDL or ApoA1, HDL free cholesterol levels were not signifi cantly changed in COD-fed Pltp KO mice compared with WT animals ( 8 ) . Therefore, we beover, COD-fed Pltp KO ( 2, 26 ) mice and Pltp KO/ Apoe KO mice accumulated nonHDL-sized, lamellar-shaped particles ( Fig. 2 ) . These fi ndings suggest that mechanisms governing the COD-induced free cholesterol accumulation are common to Pltp KO and Pltp KO/ Apoe KO mice. Therefore, we utilized the simpler and more generalizable Pltp KO mouse model to study how COD infl uences free cholesterol accumulation in Pltp -defi cient mice. We confi rmed signifi cantly reduced by 33% in Pltp KO mice compared with WT controls ( Fig. 8B ) . Biliary phospholipid output was also diminished by 25% in Pltp KO mice ( Fig. 8C ) . These results indicate that in the COD-fed state, Pltp deficiency could reduce hepatic secretion of biliary cholesterol, which could contribute to the accumulation of plasma free cholesterol in these mice. However, there were no significant changes in lipid concentrations of hepatic biles between Pltp KO and WT mice (supplementary Table II ). We also measured plasma total bile acids in these mice ( Fig. 9 ). Feeding COD, compared with the chow diet, increased the levels of bile acids in plasma in both Pltp KO and WT mice. Although there was a trend for higher levels of plasma bile acids in COD-fed Pltp KO mice compared with WT controls, this difference was not statistically signifi cant.
DISCUSSION
In this study, we found that free cholesterol and phospholipid accumulation in plasma can overcome the antiatherogenic properties endowed by Pltp defi ciency in Apoe KO mice. Moreover, we observed that under COD feeding conditions, hepatic secretion of biliary cholesterol is signifi cantly reduced in Pltp KO mice, which could contribute to the accumulation of plasma free cholesterol in these mice.
Previously, we reported that on the chow diet, Pltp KO/ Apoe KO mice have signifi cantly less atherosclerotic lesions than Apoe KO mice, and we attributed this phenomenon to lower triglyceride-rich lipoprotein production, less lipoprotein oxidation, and anti-infl ammation in Pltp KO/ Apoe KO mice ( 4, 32 ) . In this study, COD-fed Pltp KO/ Apoe KO accumulate plasma free cholesterol and phospholipds. Under these conditions, Pltp defi ciency offers no net protection against atherosclerosis.
NonHDL particles from COD-fed Pltp KO/ Apoe KO mice were more susceptible to oxidation than the controls. Oxidized lipoproteins activate the vessel endothelium, induce foam cell formation, and promote atherosclerosis. When fed a chow diet, Pltp KO/ Apoe KO mice have nonHDL particles that have more vitamin E and are less susceptible to oxidation than controls ( 32 ) However, when fed COD, it appears that Pltp KO/ Apoe KO mice accumulate oxidizible phospholipids disproportionately to antioxidants on non-HDL lipoproteins, which may aggravate atherosclerosis.
lieved that studying VLDL free cholesterol secretion could refl ect the liver's contribution to plasma nonHDL lipoprotein free cholesterol concentrations. Mice were fasted for 16 h and then injected with P-407. Following the inhibitor administration, plasma lipids were measured at 1 and 2 h. We did not observe any signifi cant increases in free cholesterol ( Fig. 7A ), total cholesterol ( Fig. 7B ) , or phospholipid ( Fig. 7C ) secretion in Pltp KO versus WT mice. However, Pltp KO mice secreted less triglyceride than WT mice ( Fig.  7D ), consistent with a previous report on decreased ApoB secretion in Pltp KO mice ( 4 ) .
After exhausting the obvious processes involved in free cholesterol metabolism, we further explored whether hepatic secretion of biliary free cholesterol was affected in COD-fed Pltp KO mice. Biliary secretion is a major pathway for removal of free cholesterol and phospholipids from the body. Patients with biliary cholestasis ( 28, 29 ) and mice having bile duct ligation ( 30, 31 ) experienced elevated levels of plasma free cholesterol and phospholipids. Therefore, we determined bile fl ow rates and hepatic outputs of biliary free cholesterol and phospholipids in COD-fed Pltp KO and WT mice.
Hepatic bile samples were collected at 1 and 2 h after a successful cannulation of the common bile duct, and bile fl ow rates were subsequently determined. Bile lipids from each time point were also measured. Pltp KO mice had a 42% lower bile fl ow rate compared with WT controls ( Fig.  8A ) . Moreover, hepatic output of biliary cholesterol was and this may contribute to increased atherosclerosis in the mice ( 38 ) . We also found that human plasma sphingomyelin levels and sphingomyelin/phosphatidylcholine ratios are independent risk factors for coronary heart disease ( 39, 40 ) . Furthermore, a sphingomyelin-enriched (1%) diet signifi cantly increases plasma sphingomyelin levels, LDL aggregation, and atherosclerotic lesions in LDLreceptor KO mice ( 41 ) . These data suggest that plasma sphingomyelin plays a critical role in the development of atherosclerosis.
We addressed the possible mechanisms involved in COD-induced free cholesterol, phospholipid, and sphingomyelin accumulation in Pltp KO mice. Given the role of SR-B1 in cholesterol metabolism and the increased plasma free cholesterol levels in Srb1 KO mice, we assayed for liver SR-B1 levels and found no change between COD-fed Pltp KO/ Apoe KO and control mice (supplementary Fig.  I ), Previously, we showed that COD-fed Pltp KO also have unaltered SR-B1 levels but might have dysfunctional SR-BI ( 8 ) . We speculate that SR-B1 may also be dysfunctional in COD-fed Pltp KO/ Apoe KO mice, which may at least partly explain the plasma free cholesterol accumulation. Separately, LCAT regulates plasma free cholesterol by converting free cholesterol into cholesteryl ester; therefore, LCAT activity should be relevant in COD-fed Pltpdefi cient mice. However, in a previous study, we measured LCAT activity in COD-fed Pltp KO and WT mice and did Free cholesterol is generally considered to be an atherogenic lipid. There is a body of evidence linking free cholesterol to cytotoxicity and infl ammation, but there have been few animal models to test the in vivo consequences of elevated free cholesterol in plasma. Scavenger receptor B-I (SR-BI) defi ciency accelerates plasma free cholesterol accumulation and leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in Apoe KO mice ( 14, 33 ) . Lecithin:cholesterol acyltransferase ( Lcat ) defi ciency decreases plasma total cholesterol levels, but it increases the free cholesterol/ cholesteryl ester ratio with or without Apoe -defi cient background ( 34 ) . Reduced atherosclerosis was observed in the Lcat KO/ Apoe KO mice ( 34 ) . We have shown that CODfed Pltp KO mice are an animal model with elevated plasma free cholesterol. Furthermore, free cholesterol accumulation in Pltp KO mice is associated with loss of protection against atherosclerosis.
In this study, we also observed that COD signifi cantly increases nonHDL lipoprotein sphingomyelin, which may also promote atherogenesis. NonHDL lipoproteins are the major carriers of sphingomyelin ( 35 ) . The ratio of sphingomyelin to phosphatidylcholine is increased by 5-fold in VLDL from hypercholesterolemic rabbits ( 36 ) . We have found that plasma sphingomyelin levels in Apoe KO mice are 4-fold higher than those in WT mice ( 37 ) , cholesterol or as bile acids after its conversion by liver enzymes, and secretion into the plasma via newly assembled VLDL lipoproteins or through plasma membrane bound ABC transporters. We observed that feeding COD results in accumulation of plasma free cholesterol and phospholipids on nonHDL particles in Pltp KO mice. K O mice do not secrete more free cholesterol via VLDL than WT controls. We propose that COD feeding impairs hepatic biliary secretion of free cholesterol in Pltp KO mice and not fi nd signifi cant differences ( 2 ) . The liver and intestine are the major contributors of steady-state plasma lipid levels. Here we found that liver secretion of free cholesterol and phospholipids on VLDL was not different between COD-fed Pltp -defi cient mice and WT controls. Furthermore, although changes in the levels of liver sphingomyelin synthase result in changes of plasma sphingomyelin ( 19 ) , there was no change in liver sphingomyelin synthase (SMS) activity between COD-fed Pltp KO/ Apoe KO mice and Apoe KO mice (supplementary Fig.  II) . Moreover, the mice used in these studies had been fasted, making intestinal absorption of free cholesterol from the diet a negligible factor.
In this study, we found that COD-fed Pltp KO mice have decreased hepatic outputs of biliary cholesterol and phospholipids. This is reminiscent of other scenarios in which biliary lipid outputs are impeded either through bile duct ligation ( 30, 31 ) or due to biliary cholestasis ( 28, 42 ) , and plasma free cholesterol and phospholipids are consequently elevated. Under those circumstances, the excess free cholesterol and phospholipids circulate on an abnormal lipoprotein termed "lipoprotein X," which appear as lamellar structures under the electron microscope ( 42 ) . Interesting, we have reported the existence of lamellar lipoproteins in Pltp KO mice fed COD ( 2 ), and we observed these particles in COD-fed Pltp KO/ Apoe KO as well ( Fig. 2 ) .
The liver maintains free cholesterol homeostasis through esterifi cation by ACAT, secretion into bile as free Fig. 8 . COD-fed Pltp KO mice have decreased bile fl ow rates and biliary lipid outputs. The common bile ducts were cannulated in COD-fed Pltp KO and WT mice, and hepatic bile samples were collected at the fi rst and second h of biliary washout. Compared with WT controls, COD-fed Pltp KO mice had a decrease in bile fl ow rate (A), biliary cholesterol output (B), and biliary phospholipid output (C). Data is represented as mean ± SD (n = 4 per group). * P < 0.05. Abbreviations: COD, coconut oil-enriched high-fat diet; KO, knockout; PLTP, phospholipid transfer protein; WT, wild-type. Fig. 9 . Feeding COD increases plasma total bile acids. Total bile acids in fasting plasma were assayed in Pltp KO and WT mice (n = 5 per group), which were fed the chow diet or COD for 2 weeks. Data is represented as mean ± SD. * P < 0.05. Abbreviations: COD, coconut oil-enriched high-fat diet; KO, knockout; PLTP, phospholipid transfer protein; WT, wild-type. results in secretion of free cholesterol on an abnormal lipoprotein into the plasma.
The role of Pltp in hepatic secretion of biliary lipids is an interesting topic which deserves more attention. Pltp is under the transcriptional control of FXR ( 6 ) and LXR ( 5 ), two important regulators of biliary lipid metabolism. Pltp overexpressing mice have higher biliary bile acid, cholesterol, and phospholipid outputs compared with WT controls ( 7 ) . Pltp KO mice on the chow diet do not display altered biliary bile acid output ( 43 ) . In this study, we show that Pltp KO mice on COD have a decrease in biliary cholesterol secretion and an increase in free cholesterol in plasma. Furthermore, phosphatidylcholine transfer protein (PC-TP), another protein which mediates transfer of phosphatidylcholine, has been implicated in biliary lipid secretion. Pc-tp -defi cient mice have impaired biliary lipid secretion when fed a high-fat, high-cholesterol diet but not when fed a chow diet ( 44 ) . Although PLTP is generally thought to function in the circulation, there is evidence for an intracellular role of PLTP ( 4, 45 ) . Perhaps phospholipid transfer, by PLTP or PC-TP, becomes important for biliary lipid secretion when redundant factors are overwhelmed by certain high-fat diets.
In summary, COD-fed Pltp KO mice are no longer protected from atherosclerosis and have impaired biliary lipid secretion. These fi ndings emphasize the complexity and importance of the interplay between diet and genetics on atherogenesis.
